Patents by Inventor Dinesh Dayaramji Chakole

Dinesh Dayaramji Chakole has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090214648
    Abstract: A pharmaceutical dosage form comprising diphenhydramine, or a pharmaceutically acceptable salt thereof, and ibuprofen, wherein the dosage form provides both diphenhydramine and ibuprofen in a single monolayer tablet, and processes for preparation of dosage forms.
    Type: Application
    Filed: February 13, 2009
    Publication date: August 27, 2009
    Inventors: Malathi Kandakatla, Dinesh Dayaramji Chakole, Pradeep Kumar Reddy Chellekkagari, Venkata Sivareddy Pallempalli, Raviraj Sukumar Pillai
  • Publication number: 20040001886
    Abstract: The present invention relates to the stable solid orally administrable pharmaceutical formulation of Amlodipine Maleate. The invention also describes the process of producing such stable formulations and more specifically a direct compression method of producing tablet formulations. The tablet formulation of Amlodipine Maleate thus prepared is bioequivalent to the tablets containing Amlodipine Besylate salt commercially available with the brand name of Norvasc. The formulation also avoids the common problem of sticking observed during manufacturing.
    Type: Application
    Filed: April 17, 2003
    Publication date: January 1, 2004
    Applicant: DR. REDDY'S LABORATORIES LIMITED
    Inventors: Dinesh Dayaramji Chakole, Pallempalli Venkata Siva Reddy, Billa Praveen Reddy, Vipin Tatyasaheb Dhanorkar, Mailatur Sivaraman Mohan
  • Publication number: 20030180354
    Abstract: The present invention relates to the stable solid orally administrable pharmaceutical formulation of Amlodipine Maleate. The invention also describes the process of producing such stable formulations and more specifically a direct compression method of producing tablet formulations. The tablet formulation of Amlodipine Maleate thus prepared is bioequivalent to the tablets containing Amlodipine Besylate salt commercially available with the brand name of Norvasc. The formulation also avoids the common problem of sticking observed during manufacturing.
    Type: Application
    Filed: September 13, 2002
    Publication date: September 25, 2003
    Applicant: DR. REDDY'S LABORATORIES LIMITED
    Inventors: Dinesh Dayaramji Chakole, Pallempalli Venkata Siva Reddy, Billa Praveen Reddy, Vipin Tatyasaheb Dhanorkar, Mailatur Sivaraman Mohan